These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2571615)

  • 21. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
    Palmer DG; Dunckley JV
    Aust N Z J Med; 1973 Oct; 3(5):461-6. PubMed ID: 4204711
    [No Abstract]   [Full Text] [Related]  

  • 22. Scarring alopecia following gold therapy.
    Burrows NP; Grant JW; Crisp AJ; Roberts SO
    Acta Derm Venereol; 1994 Nov; 74(6):486. PubMed ID: 7701895
    [No Abstract]   [Full Text] [Related]  

  • 23. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
    Manthorpe R; Tvede N; Bendixen G
    Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic gold therapy.
    Papp KA; Shear NH
    Clin Dermatol; 1991; 9(4):535-51. PubMed ID: 1822410
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):373-82. PubMed ID: 3139562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy].
    Chichasova NV; Kanevskaia MZ; Slobodina GA; Varshavskiĭ VA; Krel' OV; Krel' AA
    Ter Arkh; 1991; 63(5):97-101. PubMed ID: 1679571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vasomotor (nitritoid) reactions induced by sodium aurothiomalate and enap].
    Murav'ev IuV; Tsapina TN
    Ter Arkh; 2002; 74(5):79-80. PubMed ID: 12087916
    [No Abstract]   [Full Text] [Related]  

  • 33. Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines.
    Svensson A; Möller H; Björkner B; Bruze M; Leden I; Theander J; Ohlsson K; Linder C
    BMC Dermatol; 2002; 2():2. PubMed ID: 11860615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
    Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S
    Arthritis Rheum; 1985 Nov; 28(11):1211-8. PubMed ID: 3933523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All that glitters may be HMGB1: an interview with Dr. Ulf Andersson.
    Ulf A
    J Leukoc Biol; 2008 Jan; 83(1):39-40. PubMed ID: 17965336
    [No Abstract]   [Full Text] [Related]  

  • 37. A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
    Bendix G; Bjelle A
    Ann Rheum Dis; 1996 Mar; 55(3):169-76. PubMed ID: 8712879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies.
    Ward JR
    J Rheumatol Suppl; 1990 Nov; 25():18-23. PubMed ID: 1980313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 40. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.